- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01986179
Comparing Remote Interpreter Modalities in the Pediatric Emergency Department
Impact of Remote Interpreter Modality on Comprehension, Communication Quality, and Consistency of Interpreter Use in the Pediatric Emergency Department
Professional interpretation improves quality of care for patients with limited English proficiency (LEP). However, many health care settings lack access to professional interpreters, and even in locations with good access, logistical factors and perceived barriers have limited their widespread use. Remote methods of professional interpretation, including telephone and video, hold great promise for expanding access, but only limited data exist on the relative impacts of these modalities on patient care and provider uptake. Comparing how these modalities impact multiple aspects of health care quality, including family comprehension, provider communication, and consistency of provider interpreter use will inform dissemination of strategies for delivery of safe, efficient, and equitable care to LEP families.
Aim 1: To determine whether randomly assigned remote interpreter modality (telephone versus video) impacts parent-reported quality of communication and interpretation, diagnosis comprehension, and length of stay (LOS) among LEP Spanish-speaking families seen in a pediatric Emergency Department (ED).
Hypothesis 1: Parent-reported quality of communication and interpretation and parent diagnosis comprehension will be higher among families assigned to video interpretation compared to telephone interpretation.
Hypothesis 2: LOS will not differ between families assigned to video and telephone interpretation.
Aim 2: To determine whether assigned interpreter modality is associated with provider decision to communicate without professional interpretation.
Hypothesis 3: Parent-reported provider communication without professional interpretation (e.g. using the patient or a family member to interpret for some part of the visit) will be lower for families assigned to video interpretation compared to telephone interpretation.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Washington
-
Seattle, Washington, Vereinigte Staaten, 98105
- Seattle Children's Hospital Emergency Department
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Preferred language for medical care of Spanish
- At least one primary caregiver requires interpretation
- Presenting to Seattle Children's ED during recruiting hours
Exclusion Criteria:
- Triage level 1 (life-threatening illness)
- No parent or legal guardian present
- Reason for visit is concern for abuse
- reason for visit is primary behavioral or psychiatric complaint
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Telephone Interpretation
These families will be assigned to use telephone interpretation throughout the ED visit.
|
Professional interpretation provided over the phone by a national network of certified medical interpreters
|
|
Experimental: Video Interpretation
These families will be assigned to use video interpretation throughout the ED visit.
|
Professional interpretation provided over video by a national network of certified medical interpreters
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Communication Quality
Zeitfenster: Once, 1-7 days after the ED visit
|
We will use the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Child Visit Survey 2.0 communication composite, which includes 5 items.
|
Once, 1-7 days after the ED visit
|
|
Interpretation Quality
Zeitfenster: Once, 1-7 days after ED visit
|
Interpretation quality will be measured with the Interpreter Satisfaction Survey (7 items).
|
Once, 1-7 days after ED visit
|
|
Diagnosis Comprehension
Zeitfenster: Once, 1-7 days after ED visit
|
Parents will be asked to name their child's diagnosis.
Clinician-recorded diagnosis will be obtained from chart review for comparison.
Responses will be classified as correct, incorrect, or vague/incomplete, using a method we have employed previously.
|
Once, 1-7 days after ED visit
|
|
Consistency of Interpreter Use
Zeitfenster: Once, 1-7 days after ED visit
|
Parents will be asked to report on the frequency with which providers used each of a list of potential communication methods (e.g.
telephone interpreter, family or friend, spoke in English without an interpreter present).
Response options are never, sometimes, frequently, or always.
|
Once, 1-7 days after ED visit
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Length of ED stay
Zeitfenster: Once, after ED visit
|
Time from arrival in Emergency Department to discharge home or admission to the hospital.
|
Once, after ED visit
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: K. Casey Lion, MD, MPH, Seattle Children's Hospital
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Lion KC, Gritton J, Scannell J, Brown JC, Ebel BE, Klein EJ, Mangione-Smith R. Patterns and Predictors of Professional Interpreter Use in the Pediatric Emergency Department. Pediatrics. 2021 Feb;147(2). pii: e20193312. doi: 10.1542/peds.2019-3312.
- Lion KC, Brown JC, Ebel BE, Klein EJ, Strelitz B, Gutman CK, Hencz P, Fernandez J, Mangione-Smith R. Effect of Telephone vs Video Interpretation on Parent Comprehension, Communication, and Utilization in the Pediatric Emergency Department: A Randomized Clinical Trial. JAMA Pediatr. 2015 Dec;169(12):1117-25. doi: 10.1001/jamapediatrics.2015.2630.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 14647
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .